If I remember correctly, there is a paragraph in the agreement of the partnership between Frequency Therapeutics and Astellas that states that there will be a monetary payout from Astellas when the first patient is injected in Europe in a Phase 2 study.Hey, do you think that once Phase 2a clinical trials are completed, Frequency Therapeutics will do clinical trials in other locations (outside of the US)?
So I'm pretty sure it's in the plans, but I guess it depends on how everything goes in the currently running phases.